申请人:AstraZeneca AB
公开号:US06489322B1
公开(公告)日:2002-12-03
There are provided novel compounds of formula (I)
wherein R1 represents a 2-thienyl or 3-thienyl ring and R2 represents hydrogen or C 1 to 4 alkyl and optical isomers and racemates thereof and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are selective inhibitors of the neuronal isoform of nitric oxide synthase.
提供了以下化合物的新颖化合物(I)的公式,其中R1代表2-噻吩基或3-噻吩基,R2代表氢或C1至C4烷基及其光学异构体和消旋体以及药学上可接受的盐;以及它们的制备过程,含有它们的组合物以及它们在治疗中的用途。这些化合物是神经型一氧化氮合酶的选择性抑制剂。